SCHEMBL7908113

SCHEMBL7908113

CC1Cn2c(=O)[nH]c3cccc(c32)CN1Cc1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 16/20 0.49
DRD2 P14416 6/20 0.49
DRD3 P35462 6/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7896210 0.81 HTR1A (0.55) HTR1ADRD2DRD3
SCHEMBL6363122 0.81 HTR1A (0.55) HTR1ADRD2DRD3
SCHEMBL9676278 0.81 HTR1A (0.51) HTR1ADRD2DRD3
SCHEMBL9676122 0.81 HTR1A (0.51) HTR1ADRD2DRD3
SCHEMBL7904426 0.80 HTR1A (0.47) HTR1ADRD2DRD3
SCHEMBL9676250 0.80 HTR1A (0.47) HTR1ADRD2DRD3
SCHEMBL7896171 0.77 HTR1A (0.52) HTR1ADRD2DRD3
Hydrochloric Acid SCHEMBL7908041 0.77 HTR1A (0.48) HTR1ADRD2DRD3
SCHEMBL7905521 0.76 HTR1A (0.48) HTR1ADRD2DRD3
SCHEMBL9127389 0.71 DRD2 (0.72) HTR1ADRD2DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-1275582-A None JP disclosed
US-6201119-B1 2,3,4,5-TETRAHYDRO-1H-1,4-BENZODIAZEPIN-9-AMINE COMPOUNDS USEFUL AS INTERMEDIATES TO ANTIVIRALS JANSSEN PHARMACEUTICA N.V. (BE) 2001-03-13 US disclosed
US-5371079-A Administering to inhibit replication of HIV-1 in human cells JANSSEN PHARMACEUTICA N.V. (BE) 1994-12-06 US disclosed
US-5270464-A Anti-HIV-1 tetrahydroimidazo[1,4]benzodiazepin-2-(thi) ones JANSSEN PHARMACEUTICA N.V. (BE) 1993-12-14 US disclosed
JP-H01275582-A TETRAHYDROIMIDAZO(1,4)BENZODIAZEPIN-2-ONE COMPOUND JANSSEN PHARMACEUT NV 1989-11-06 JP disclosed